Sept. 8, 2025
WW today announced the launch of Weight Watchers for Menopause, a program that is designed to support women through every stage of the menopause journey, from perimenopause to post-menopause. To launch the program, WeightWatchers is partnering with Grammy and Emmy Award-winning and Oscar-nominated actress, producer, entrepreneur, and health advocate Queen Latifah as its first official spokeswoman.
From one-on-one guidance with menopause-trained clinicians and access to evidence-based treatments, to a tailored version of the Points® Program, fitness designed for strength and stability, and workshops led by coaches who understand this stage of life, the program offers women everything they need to feel supported, informed, and empowered.
“For more than six decades, WeightWatchers has evolved with the science to meet the changing needs of our members,” said Tara Comonte, CEO of WeightWatchers. “With this first-of-its-kind menopause program we’re proud to deliver truly comprehensive care in a single plan, bringing together specialized medical expertise, science-backed nutrition, lifestyle tools and a compassionate community. This program sets a new standard for the industry and women’s health, empowering millions to feel healthier, stronger, and more confident as they navigate menopause and beyond.”
In studies, women of menopausal age who followed WeightWatchers’ nutritional guidance lost nearly four times more weight than those trying to manage on their own. For members seeking additional support, WeightWatchers Clinic has expanded to include clinicians specifically trained in menopause care. These members receive comprehensive consultations, individualized care plans, and, when appropriate, prescription options such as HRT, GLP-1s, or other evidence-based treatments, all monitored by licensed clinicians. In fact, women of menopausal age enrolled in WeightWatchers Clinic lost on average 18.6% of their body weight (40.1 lbs) in just one year. Emerging research from the Mayo Clinic has found that postmenopausal women receiving hormone therapy in combination with GLP-1 semaglutide achieved approximately 30% greater weight loss than those using the GLP-1 alone.
Commentary
This is a very good addition to WW’s offerings. Many women are affected by menopausal weight gain. and we think that Queen Latifah will be an appropriate and positive spokesperson for the program. Why hasn’t WW thought of this sooner?
LEEARN MORE: About The Commercial Weight Loss Market – Report by Marketdata LLC
Marketdata LLC has just published a new report: “The U.S. Weight Loss Market: Commercial (non-medical) Programs & Products”, March 2025. This is a 220-page analysis of commercial weight loss programs/companies and how they have been affected by and respond to the onslaught of the GLP-1 drugs competition.
The $38 billion U.S. commercial weight loss market is 15% larger than in 2020, but has had to pivot to adjust to huge competition from the popular GLP-1 drugs. The large commercial chains have been hurt the most since 2022. The business has gone virtual, and some competitors have added the GLP-1 drugs to their programs to position themselves for a new future.
However, some commercial markets have held up well. Diet soft drinks have shown surprising strength, and high protein meal replacements have been positioned as an adjunct to the weight loss drugs. The weight loss apps market is growing strongly. The ranks of commercial weight loss centers have been thinned, and franchising is all but dead as a growth model.
Some Report Findings::
- Marketdata estimates that the U.S. commercial (non-medical) weight loss market, for programs, products and services, was worth $38.4 billion in 2024, down slightly from $38.8 billion in 2022. Commercial services represent 53% of the $72.2 billion total market now, down from 82% in 2020, prior to the GLP-1 boom.
- The commercial weight loss programs market segment contracted by 29.2% in 2023, to $3.24 billion, and another 23.7% to $2.47 billion in 2024, due to competition from GLP-1s drugs. This amounts to a 56% decline in just two years.
- Commercial weight loss companies have lost $2 billion in revenues since 2022 due to the competition from GLP-1 drugs. Jeny Craig went bankrupt, Profile Plan closed, and NutriSystem’s private equity parent Wellful is having debt issues.
- The “average” weight loss center had annual receipts of $646,250 in 2022. But, sales have fallen since then, to $484,000 per center in 2024.
- There may be an opportunity for commercial weight loss firms to post some growth in the second half of 2025. The GLP-1s shortage is over, and the compounding pharmacies have to stop making these meds as of May 22. Consumers will then have to pay full price for the brand name meds. Many will opt for less costly (non-medical) diet programs.
- The business has gone virtual. Operating a retail, brick & mortar weight loss center or franchise has become too difficult in this era, with rising real estate and staff costs. Many businesses have pivoted to a virtual delivery model, which can be scaled larger and quicker, and is more profitable.
Purchase The Report:
The report’s description and Table of Contents are found at this website, see home page, Off The Shelf Market Reports, red link for Diet Market – Our Specialty, or contact us at 813-971-8080 and we’ll email them to you. The report contains 62 tables and charts. Price: $995. A 25-page, $99 Overview Summary report is also available.
Included… dollar value & growth rates of all major commercial weight loss market segments (early 1980s to 2024 and 2025 & 2028 forecasts), latest market trends and company developments, status reports for: diet soft drinks, artificial sweeteners, commercial weight loss centers, multi-level marketing diet plans, retail and MLM meal replacements and weight loss supplements, and low-cal frozen entrees. Analysis of the medical weight loss programs market and competition from MDs, hospitals, medical clinic chains, and telehealth.
The report includes a 35-year revenue analysis of the market through past recessions and fad diet cycles, plus weight loss center franchising, and extensive national/state commercial centers’ operating ratios. Rankings & revenues of top commercial chains, brand sales, and a Reference Directory. Competitor profiles for: Weight Watchers, Jenny Craig, NutriSystem, Medifast, Herbalife, Noom, MyFitness Pal, Slim-Fast (Glanbia), Simply Good Foods (Atkins Nutritionals), Slimgenics, Profile by Sanford, BeachBody, Metabolic Research, Visalis Life Sciences, Isagenix, Shaklee, AMWAY (Quixtar), and Nu-Skin.